Hillstream BioPharma Inc. [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19
	10-K	10-K	10-K	S-1/A
Revenues	0.0	0.0	0.0	0.4
Revenue growth			-100.0%
Cost of goods sold	0.0	0.0	0.0	0.4
Gross profit	0.0	0.0	0.0	0.0
Gross margin				0.0%
Selling, general and administrative [+]	4.6	1.4	0.7	0.6
General and administrative	4.6	1.4	0.7	0.6
Research and development	2.3	1.8	0.8
Other operating expenses				0.4
EBIT [+]	-6.9	-3.2	-1.5	-1.0
EBIT growth	114.5%	111.2%	52.7%
EBIT margin				-269.7%
Non-recurring items [+]			0.3	0.4
In-process research & development			0.3	0.4
Interest expense	1.6	0.8	0.2	0.1
Interest expense	1.6	0.8	0.2	0.1
Other income (expense), net		1.8	-0.4	0.0
Pre-tax income	-8.5	-2.2	-2.4	-1.5
Income taxes	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%
Net income	-8.5	-2.2	-2.4	-1.5
Net margin				-413.7%

Basic EPS [+]	($0.75)	($0.35)	($0.38)	($0.41)
Growth	115.7%	-8.9%	-6.3%
Diluted EPS [+]	($0.75)	($0.35)	($0.38)	($0.41)
Growth	115.7%	-8.9%	-6.3%

Shares outstanding (basic) [+]	11.3	6.4	6.3	3.8
Growth	78.0%	0.2%	69.1%
Shares outstanding (diluted) [+]	11.3	6.4	6.3	3.8
Growth	78.0%	0.2%	69.1%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.